C-reactive protein, statins, and cardiovascular risk: what can JUPITER teach us?
- PMID: 19393472
- DOI: 10.1053/j.ajkd.2009.03.003
C-reactive protein, statins, and cardiovascular risk: what can JUPITER teach us?
Comment on
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9. N Engl J Med. 2008. PMID: 18997196 Clinical Trial.
Similar articles
-
Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.Future Cardiol. 2009 May;5(3):231-6. doi: 10.2217/fca.09.8. Future Cardiol. 2009. PMID: 19656039 Clinical Trial.
-
Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.Expert Rev Cardiovasc Ther. 2009 Sep;7(9):1041-56. doi: 10.1586/erc.09.93. Expert Rev Cardiovasc Ther. 2009. PMID: 19764857
-
The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.Ther Adv Cardiovasc Dis. 2009 Aug;3(4):309-15. doi: 10.1177/1753944709337056. Epub 2009 May 21. Ther Adv Cardiovasc Dis. 2009. PMID: 19460829 Review.
-
The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin).Postgrad Med. 2009 May;121(3):113-8. doi: 10.3810/pgm.2009.05.2010. Postgrad Med. 2009. PMID: 19491548 Review.
-
[JUPITER study, more reason to give statins as preventive measure - commentary].Kardiol Pol. 2009 Mar;67(3):346-7. Kardiol Pol. 2009. PMID: 19469067 Polish. No abstract available.
Cited by
-
ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK.J Lipid Res. 2013 Aug;54(8):2095-2108. doi: 10.1194/jlr.M035212. Epub 2013 May 24. J Lipid Res. 2013. PMID: 23709692 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials